4//SEC Filing
Reich Siegfried 4
Accession 0001209191-21-018435
CIK 0001595893other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:56 PM ET
Size
26.9 KB
Accession
0001209191-21-018435
Insider Transaction Report
Form 4
Reich Siegfried
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-03-04$103.65/sh−6,220$644,703→ 21,350 total - Sale
Common Stock
2021-03-04$105.71/sh−3,103$328,018→ 16,247 total - Sale
Common Stock
2021-03-04$107.85/sh−3,679$396,780→ 5,852 total - Sale
Common Stock
2021-03-04$110.59/sh−700$77,413→ 4,445 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-04−35,550→ 114,450 totalExercise: $51.28Exp: 2030-03-01→ Common Stock (35,550 underlying) - Exercise/Conversion
Common Stock
2021-03-04$51.28/sh+35,550$1,823,004→ 39,395 total - Sale
Common Stock
2021-03-04$102.01/sh−3,005$306,540→ 36,390 total - Sale
Common Stock
2021-03-04$102.87/sh−8,820$907,313→ 27,570 total - Sale
Common Stock
2021-03-04$104.97/sh−2,000$209,940→ 19,350 total - Sale
Common Stock
2021-03-04$107.13/sh−6,716$719,485→ 9,531 total - Sale
Common Stock
2021-03-04$108.92/sh−707$77,006→ 5,145 total - Sale
Common Stock
2021-03-04$111.46/sh−600$66,876→ 3,845 total
Footnotes (12)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 23, 2020.
- [F10]The weighted average sale price for the transaction reported was $110.59, and the range of prices were between $110.05 and $110.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F11]The weighted average sale price for the transaction reported was $111.46, and the range of prices were between $111.20 and $111.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F12]25% of the shares vested on March 2, 2021 and 1/48th of the shares vest monthly thereafter over the next three years.
- [F2]The weighted average sale price for the transaction reported was $102.01, and the range of prices were between $101.37 and $102.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $102.87, and the range of prices were between $102.38 and $103.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The weighted average sale price for the transaction reported was $103.65, and the range of prices were between $103.40 and $104.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F5]The weighted average sale price for the transaction reported was $104.97, and the range of prices were between $104.46 and $105.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F6]The weighted average sale price for the transaction reported was $105.71, and the range of prices were between $105.47 and $106.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F7]The weighted average sale price for the transaction reported was $107.13, and the range of prices were between $106.53 and $107.53. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F8]The weighted average sale price for the transaction reported was $107.85, and the range of prices were between $107.54 and $108.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F9]The weighted average sale price for the transaction reported was $108.92, and the range of prices were between $108.75 and $109.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001351888
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 8:56 PM ET
- Size
- 26.9 KB